|
The biopharmaceutical market has expanded rapidly. No longer is it confined to growth hormones, insulin and red blood cell stimulating agents. Innovative science is accelerating the market into targeting a huge range of diseases from growth deficiency to arthritis, to multiple sclerosis and orphan diseases such as Fabrys disease. Are you part of this world market? Is your organisation profiting as much as it should? A brand new report is here to help you. Visiongains Exclusive World Biotech Market report analysis in-depth the value of the 2005 biopharma market. Having grown 16.5 per cent from 2004s revenues, double-digit growth of the market will continue to the end of the decade. You need to be aware of how you can succeed in this area. Composed of 9 major therapeutic areas, the market is expected to represent 17% of all prescriptions written by 2010. At this rate, biotech is now outgrowing Big Pharma - you must be informed TODAY. Biotech companies however still
face major challenges. The threat of the emergence of biogenerics is mounting, with 11 products facing patent expiry before 2007 - 5 of which are blockbusters. The Australian approval of his Sandozs Omnitrope hGH product is paving the way, and increasing pressure upon EU and US regulatory agencies to give the go ahead to biogenerics. Your competitors will be reading this report - you need to too.
Designed as an essential business aid, World Biotech Report 2005 provides the leading thorough evaluation of your market. This extensive report focuses on the following aspects:
- 1. Diseases treated by Biopharmaceuticals
- 2. In-depth analysis of succeeding in the Biopharmaceuticals Market
- 3. Current Company Revenues and Market Share, 2004
- 4. Biopharmaceutical Pipeline, 2005
- 5. Unique Biopharmaceutical Market Forecasts, specifically by Therapeutic Area, 2003-2010
- 6. A focus on the 2010 Biopharmaceuticals Market - plan to succeed now
- 7. The threat of Biogenerics
- 8. Is there an opportunity for you in the Biogeneric Market
- 9. Overcoming the Biopharmaceutical Market Challenges
- 10.Venture Capitalism and Biotech
The report provides you with in-depth market analysis for all top-selling current and major potential products to arrive before the decade ends. The report extensively identifies biopharmaceuticals market potential by analysing the latest clinical trial research. The study also examines the challenges faced by potential biotech companies and opportunities newcomers to the arena. This is the industrys premier report. Numbers are strictly limited.
Why You Must Buy This Report?
This 300 page report spanning 13 chapters features over 70 tables, 80 graphs and charts, news, insights and visiongain consultants critical opinion on leading developments. Over 120 companies are mentioned in this critical report, which reviews 2004 revenues for ALL the biopharmaceutical products featured within the market. Due to visiongains targetted consultancy work in the area, only a strict number of these reports are issued. Please order your copy now so as you do not miss out. Copies will be reserved on a strictly first-come-first-serve basis. So please contact us now.
Five key questions this report answers are:
- 1. What are the market values of the major therapeutic areas of the global biopharmaceutical market by product from, 2004 to 2010?
- 2. Who are the major companies involved in the world market today and in the future?
- 3. How imminent are biogenerics and what is their potential market value?
- 4. What strategies can be used to maximise profits in terms of the major challenges facing biotech?
- 5. Whats in the 2005 biopharmaceutical pipeline and what revenues can they reach by 2010?
| 
View Cart
